Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Clinical trial NCT06113913 · RECRUITING

Trial details

NCT number: NCT06113913
Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

Start date: 2024-04-09
Primary completion: 2026-05-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.